Scarica l'app Stockscreener
25.93
2.90%
0.73
Dopo l'orario di chiusura:
25.90
-0.03
-0.12%
Precedente Chiudi:
$25.20
Aprire:
$25.2
Volume 24 ore:
479.84K
Relative Volume:
1.19
Capitalizzazione di mercato:
$1.14B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.22%
1M Prestazione:
+78.95%
6M Prestazione:
+135.51%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$24.42
$26.45
Intervallo di 1 settimana:
$24.42
$28.37
Portata 52W:
$6.71
$28.37
Maze Therapeutics Inc Stock (MAZE) Company Profile
Nome
Maze Therapeutics Inc
Settore
Industria
Telefono
(650) 850-5070
Indirizzo
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Confronta MAZE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
25.93 | 1.11B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Iniziato | BTIG Research | Buy |
| 2025-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-08 | Iniziato | Wedbush | Outperform |
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Detecting price anomalies in Maze Therapeutics Inc. with AIJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Predicting Maze Therapeutics Inc. trend using moving averagesJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com
Goldman Sachs Group Inc. Makes New $145,000 Investment in Maze Therapeutics, Inc. $MAZE - Defense World
Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 5.2%Should You Sell? - MarketBeat
What technical models suggest about Maze Therapeutics Inc.’s comebackDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Developing predictive dashboards with Maze Therapeutics Inc. dataJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com
Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $37.00 at JPMorgan Chase & Co. - MarketBeat
What drives Maze Therapeutics Inc stock priceAnalyst Downgrades & High Yield Trading Growth - earlytimes.in
What analysts say about Maze Therapeutics Inc stockEarnings Beat Highlights & Outstanding Trading Tips - earlytimes.in
Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 4.4%Still a Buy? - MarketBeat
Maze Therapeutics (NASDAQ:MAZE) Reaches New 52-Week HighHere's Why - MarketBeat
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $32.67 Average PT from Analysts - Defense World
How hedge fund analytics apply to Maze Therapeutics Inc. stock2025 Institutional Moves & Weekly Top Performers Watchlists - newser.com
Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
HC Wainwright Reaffirms Buy Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat
Analyzing Maze Therapeutics (NASDAQ:MAZE) and Syndax Pharmaceuticals (NASDAQ:SNDX) - Defense World
Institution Moves: What’s the fair value of Maze Therapeutics Inc. stock2025 Price Momentum & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Candlestick signals on Maze Therapeutics Inc. stock todayTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Maze Therapeutics (NASDAQ:MAZE) Director Sells $464,043.28 in Stock - MarketBeat
Maze Therapeutics Inc. stock trend outlook and recovery pathNew Guidance & Free Expert Approved Momentum Trade Ideas - newser.com
Market reaction to Maze Therapeutics Inc.’s recent newsIPO Watch & Community Driven Trade Alerts - newser.com
Will Maze Therapeutics Inc. rebound enough to break even2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Maze Therapeutics, Inc. (MAZE): A Bull Case Theory - Insider Monkey
Maze Therapeutics (NASDAQ:MAZE) Receives “Buy” Rating from HC Wainwright - Defense World
Can Maze Therapeutics Inc. recover in the next quarterQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Biotech Breakouts: 3 Stocks With Massive Upside Potential - Investing.com
Tools to monitor Maze Therapeutics Inc. recovery probability2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Analyzing drawdowns of Maze Therapeutics Inc. with statistical toolsJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
Biotech Breakouts: 3 Stocks With Massive Upside Potential - sharewise.com
Maze Therapeutics (NASDAQ:MAZE) Shares Gap DownHere's Why - MarketBeat
Maze Therapeutics director Scheller sells $464k in shares By Investing.com - Investing.com Australia
New Options Available for Maze Therapeutics (MAZE) - GuruFocus
Quarterly Recap: Will COOT outperform tech stocks2025 Valuation Update & Consistent Growth Stock Picks - خودرو بانک
Maze Therapeutics Director Cashes Out in Major Stock Sale! - TipRanks
Maze Therapeutics Inc. stock daily chart insightsQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Maze Therapeutics Inc Azioni (MAZE) Dati Finanziari
Non sono disponibili dati finanziari per Maze Therapeutics Inc (MAZE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):